BioSpace News Archive

BIOASIS TECHNOLOGIES INC . today announced the appointment of Shadow Lake Group Inc. and its affiliate SLG Europe BV (“SLG”) as Business Development advisor.

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for NUZYRA ® (omadacycline) for the treatment of infections caused by Nontuberculous Mycobacteria (NTM).

Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers using Galleri test.

Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today releases details of two ancillary studies under the ProstACT program that significantly extend the evaluation of Telix’s TLX591 antibody-directed 177Lu (lutetium) therapeutic platform into areas of unmet medical need across the full prostate cancer treatment journey.

Urovant Sciences, Inc., a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced key data for GEMTESA® (vibegron) 75 mg to be presented at the 2021 Annual Meeting of the American Urological Association (AUA2021).

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Patent and Trademark Office has issued the first U.S. patent for its novel ovarian cancer vaccine technology.

The Feinstein Institutes for Medical Research, the global scientific home of bioelectronic medicine, has been awarded a multi-year $1.3 million grant from the National Institutes of Health (NIH) to study how immune signals are transmitted to the brain through the vagus nerve.

BIOTRONIK announced the results from a new study published in EUROPACE this week confirming that heart failure decompensation can be predicted early when monitored using an algorithm that combines existing remote monitoring trends and baseline risk stratification.

The rapidly growing incidence of cancer around the globe is going to be the major driving factor.

Tissue glue is used as an alternative method for wound closure that is painless, fast, and does not require a follow-up visit for removal.